Underlying scientific evidence discovery for FDA orphan drug designations from the GARD integrative knowledge graph: Towards drug discovery for rare diseases

被引：0
|
作者：
Zhu, Qian [1 ]
Dac-Trung Nguyen [1 ]
Southall, Noel [1 ]
机构：
[1] NIH, NCATS, Rockville, MD USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
110
引用
收藏
页数：1
相关论文
共 15 条
  • [11] Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
    Miller, Kathleen L.
    Fermaglich, Lewis J.
    Maynard, Janet
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [12] Integrating multi-modal deep learning on knowledge graph for the discovery of synergistic drug combinations against infectious diseases
    Ye, Qing
    Xu, Ruolan
    Li, Dan
    Kang, Yu
    Deng, Yafeng
    Zhu, Feng
    Chen, Jiming
    He, Shibo
    Hsieh, Chang-Yu
    Hou, Tingjun
    CELL REPORTS PHYSICAL SCIENCE, 2023, 4 (08):
  • [13] COORDINATING KNOWLEDGE CREATION IN MULTIDISCIPLINARY TEAMS: EVIDENCE FROM EARLY-STAGE DRUG DISCOVERY
    Ben-Menahem, Shiko M.
    von Krogh, Georg
    Erden, Zeynep
    Schneider, Andreas
    ACADEMY OF MANAGEMENT JOURNAL, 2016, 59 (04): : 1308 - 1338
  • [14] Repurposing with purpose - from discovery to rapid drug treatment of Bachmann-Bupp Syndrome as a model of the potential to treat and cure rare diseases
    Bupp, Caleb
    VanSickle, Elizabeth
    Michael, Julianne
    Vipond, Marlie
    Dalman, Abby
    Schultz, Chad
    Bachmann, Andre
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 736 - 736
  • [15] From data-based towards knowledge-based decision making: For the rapid elucidation of the most desirable chemical entities to initiate drug discovery projects
    Moureau, Florence
    Hanon, Etienne
    Bastogne, Didier
    Ledecq, Marie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
12